Making the Move from Big Pharma to Biotech: Real Stories of Risks, Rewards, Failures & Successes
Capital is pouring into life sciences at unprecedented amounts with all-time highs being reached in each of the past 8 quarters. Global demand for talent, services, space, equipment and consumables continues to grow exponentially and the FDA is fast tracking approvals like never before. All of these market trends are giving rise to startup scene that is bigger and better than ever. Learn from five experts about what it takes to make the change from Big Pharma to Biotech. Hear the real story about risks, rewards, unexpected failures and unprecedented successes.
Moderator: Lisa Pilla, Principal, CoAction Consulting, LLC
The Panel:
• Jenny Chaplin, VP Strategic Operations, Bellicum Pharmaceuticals
• Audrey Greenberg, Co-founder, Center for Breakthrough Medicines
• Laura Randa, President and CEO, Toivoa Therapeutics
• Stella K. Vnook, CEO, NAKI Therapeutics
• Amy Winnen, Vice President, Head Value Access and Policy at Fulcrum Therapeutics
Agenda
7- 7:10 Introduction
7:10- 7:50 Panel Discussion
7:50-8:20 Q&A
8:20 -8:30 Closing
Registration information
Event is open to: HBA Members and Nonmembers
Learning Objectives
- Learn more about the Biotech Executive World - Benefits, rewards and challenges
- Why executives from big pharma took the leap
- What it takes to lead in the Start-up world
Featured Speakers
Jenny
Chaplin
Vice President, Strategic Operations,
Bellicum Pharmaceuticals, Inc.
Audrey
Greenberg
Co-Founder and Chief Business Officer,
Center for Breakthrough Medicines
Amy
Winnen
Vice President, Head Value Access and Policy, Fulcrum Therapeutics,
Fulcrum Therapeutics
Pricing
| Regular Registration | $10.00 / €8.00 | $20.00 / €17.00 |
Members receive up to 50 percent discount
Event Policies
Photography Policy
By registering for this event, you acknowledge that you may be photographed, videotaped, and/or audio-taped during the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion, and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.
COVID-19 Policy
The HBA requires that all persons who participate in in-person events do so at their own risk and that each participant agrees to the following agreement before taking part in the activity and urges all participants to act in such a manner as to protect their own safety and the safety of others.
By registering for this event, I fully understand that my participation in the program is purely voluntary. I desire to participate and agree to act reasonably and prudently under the circumstances. I further understand that any HBA volunteers participating in the activity will act individually and will not represent the HBA. As a condition to my participation the activity, I waive and release the HBA and their officers, employees, and agents from any claim that I may have for any damage to property or injury to my person that may result in whole or in part from my participation.
Special Needs Policy
The HBA will make reasonable modifications to policies and programs to ensure that people with special needs can enjoy all of its programs. Contact us if you require special accommodations for this event.